Clinical trial
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.
NCT07737964 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- January 31, 2029
- Enrollment
- 366 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.